Explosive Growth Without a Product Inventory (Image Credits: Foodsafetynews.com)
U.S. Senate Democratic Whip Dick Durbin reintroduced legislation on January 15 to require dietary supplement companies to register products with the Food and Drug Administration, addressing gaps in oversight for an industry that generates more than $50 billion in annual U.S. sales.[1][2]
Explosive Growth Without a Product Inventory
The dietary supplement sector has ballooned since Congress passed the Dietary Supplement Health and Education Act in 1994. At that time, roughly 4,000 products filled the market. Today, the FDA estimates more than 100,000 supplements compete for consumer attention.[2]
DSHEA granted the FDA authority to regulate supplements but stopped short of mandating product registration. This omission left regulators without basic market data. More than 75 percent of American adults now use supplements, yet the agency lacks a comprehensive list of what’s available.[3] In 2023 alone, the FDA logged over 2,000 adverse event reports, though underreporting suggests the true figure exceeds 50,000 annually.[2]
Key Requirements of the Dietary Supplement Listing Act
The reintroduced bill directs manufacturers, packers, and distributors to submit essential details to the FDA. Companies would provide product names, full ingredient lists, electronic label copies, allergen statements, and health or structure/function claims.[2] Proprietary blend quantities would remain confidential.
The FDA would compile this data into a publicly searchable online database. Noncompliance would classify products as misbranded. This measure builds on prior versions introduced in 2022 and 2024, which did not advance.[4]
- Product name and description
- Complete ingredient list
- Label image or electronic copy
- Allergen disclosures
- Claims made on packaging
- Directions for use
Supporters and Critics Draw Battle Lines
The Council for Responsible Nutrition endorsed the bill, praising its focus on transparency without premarket approval. “Consumers deserve to know what products are on the market and what they contain – and FDA needs that same information to do its job effectively,” stated CRN President and CEO Steve Mister.[3] Other backers include the Consumer Federation of America, United States Pharmacopeia, U.S. PIRG, and Ritual.
Opposition emerged from groups like the Natural Products Association, which called the proposal a “Trojan Horse” that burdens compliant companies. The American Herbal Products Association questioned its value for small businesses and enforcement against adulterated products. A 2019 Pew survey showed nearly 90 percent of adults favor such reporting, highlighting public support amid divided industry views.[3][4]
| Supporters | Opponents |
|---|---|
| Council for Responsible Nutrition | Natural Products Association |
| Consumer Federation of America | American Herbal Products Association |
| United States Pharmacopeia |
Outbreak Spotlights Urgency for Change
Timing of the bill coincides with a Salmonella outbreak linked to Live it Up Super Greens powder, sold online including at Walmart. Health officials traced illnesses to the product, underscoring risks in the supplement supply chain.[1]
Senator Durbin stressed the need for basic oversight. “FDA – and consumers – should know what dietary supplements are on the market and what ingredients are included in them,” he said. “This is FDA’s most basic function, and the first step to protecting consumers.”[2]
Key Takeaways
- The bill creates a public FDA database without altering DSHEA’s core framework.
- It addresses a market grown from $4 billion to over $50 billion in sales.
- Public polls show strong backing for ingredient transparency.
As the supplement industry navigates calls for accountability, Durbin’s persistence signals potential momentum for reform. Will this third attempt succeed in bridging oversight gaps? Share your thoughts in the comments.
